Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Mitoxantrone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for mitoxantrone hydrochloride and what is the scope of mitoxantrone hydrochloride patent protection?

Mitoxantrone hydrochloride
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Oncol, West-ward Pharms Int, Mylan Labs Ltd, Teva Pharms Usa, Hospira, Mylan Institutional, Fresenius Kabi Usa, and Emd Serono, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for mitoxantrone hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: mitoxantrone hydrochloride

Drug Master File Entries: see list7
Suppliers / Packagers: see list4
Bulk Api Vendors: see list57
Clinical Trials: see list1,071
Patent Applications: see list7,081
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mitoxantrone hydrochloride at DailyMed

Pharmacology for Ingredient: mitoxantrone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
mitoxantrone hydrochloride
INJECTABLE;INJECTION076871-002Apr 11, 2006APRXNoYes► Subscribe► Subscribe
Fresenius Kabi Usa
mitoxantrone hydrochloride
INJECTABLE;INJECTION077496-001Apr 11, 2006APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
mitoxantrone hydrochloride
INJECTABLE;INJECTION076611-003Apr 11, 2006APRXNoNo► Subscribe► Subscribe
Mylan Institutional
mitoxantrone hydrochloride
INJECTABLE;INJECTION078980-002Apr 13, 2009APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
mitoxantrone hydrochloride
INJECTABLE;INJECTION077356-002Apr 11, 2006APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus